C11.3
Malignant neoplasm of anterior wall of nasopharynx
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of floor of nasopharynx
- Malignant neoplasm of nasopharyngeal (anterior) (posterior) surface of soft palate
- Malignant neoplasm of posterior margin of nasal choana
- Malignant neoplasm of posterior margin of nasal septum
Medical Intelligence & Overview
Malignant neoplasm of the anterior wall of the nasopharynx, classified under ICD-10 code C11.3, is a type of cancer that develops in the front part of the nasopharynx, the area behind the nose and above the back of the throat. This condition involves abnormal and uncontrolled growth of cells in this specific region, which can affect nearby structures and impact overall health. Early diagnosis and treatment are critical for improving outcomes.
Causes & Symptoms
Clinical Causes: Infection with Epstein-Barr Virus (EBV) Genetic predisposition Environmental exposures, such as consumption of certain preserved foods Exposure to stimuli or irritants in the occupational setting Dietary factors, including high intake of salt-preserved foods Smoking and tobacco use Radiation exposure
Key Symptoms: Nasal congestion or blockage Nasal bleeding (epistaxis) Unexplained nasal discharge, sometimes blood-tinged Persistent sore throat or a feeling of fullness in the ear Facial pain or numbness around the face Swelling or a lump in the neck due to lymph node involvement Hearing loss or ringing in the ears Difficulty swallowing or a feeling of a lump in the throat Unintentional weight loss and fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: To determine the presence of a malignant neoplasm in the anterior wall of the nasopharynx, healthcare providers may utilize several diagnostic approaches including endoscopic examination, biopsy, imaging studies such as MRI or CT scans, and blood tests to assess overall health and potential metastasis. These tests help to define the extent and exact location of the tumor, guiding appropriate treatment strategies.
Treatment Protocols: Treatment options for malignant neoplasm of the anterior nasopharynx usually involve a combination of therapies, tailored to the individual patient's condition. Common approaches include: - Radiation therapy targeted at the tumor site - Chemotherapy to destroy cancer cells - Surgical procedures, which may involve removal of tumor tissue or affected lymph nodes - Targeted therapies or immunotherapy in specific cases Multidisciplinary care teams work closely to develop a comprehensive treatment plan aimed at controlling the disease and preserving quality of life.
Clinical Advice & FAQs
Billing Guidance
Is C11.3 a billable ICD-10 code?
Yes, C11.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C11.3?
Clinical documentation must specify the nature of Malignant neoplasm of anterior wall of nasopharynx and any associated comorbidities for accurate reporting.
Cite this Clinical Reference